Bristol-Myers Squibb Company
Location
New Jersey
Founded
1887-04-10
Website
Risk Signals
10470 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Pharmaceutical Preparations), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Bristol-Myers Squibb Company
Live alerts from global media, monitored by Business Radar
2024-09-06 (vidal.fr)
FERVEX ADULTS RASPBERRY, batch withdrawal
Following the observation, during routine tests, of atypical results on 4 non-marketed batches, all batches of FERVEX ADULTES RASPBERRY granules
Read more
2024-06-22 (vidal.fr)
MUCOMYST powder for oral solution: batch recall of sachet and bottle presentations
Following the investigations carried out as part of the recall of batches of FERVEX, a recall of batches of MUCOMYST (acetylcysteine) was decided as a precautionary measure.
Read more
2024-06-22 (vidal.fr)
MUCOMYST powder for oral solution: batch recall of sachet and bottle presentations
Following the investigations carried out as part of the recall of batches of FERVEX, a recall of batches of MUCOMYST (acetylcysteine) was decided as a precautionary measure.
Read more
2020-09-17 (reuters.com)
Bristol-Myers recalls blood pressure drug Avalide
Bristol-Myers Squibb Co is recalling 60 million tablets of the blood pressure medication Avalide in the United States and Puerto Rico.
Read more
2020-09-17 (reuters.com)
Bristol-Myers recalls blood pressure drug Avalide
Bristol-Myers Squibb Co is recalling 60 million tablets of the blood pressure medication Avalide in the United States and Puerto Rico.
Read more
2020-09-17 (reuters.com)
Bristol-Myers recalls blood pressure drug Avalide
Bristol-Myers Squibb Co is recalling 60 million tablets of the blood pressure medication Avalide in the United States and Puerto Rico.
Read more
2020-08-18 (endpts.com)
Under the gun after Opdivo setbacks, Bristol-Myers Squibb names a new chief scientist
Hot on the heels of a series of painful setbacks for its marquee program for Opdivo, Bristol-Myers Squibb $BMY is bringing in a new chief scientific officer.
Read more
2020-06-17 (consumerreports.org)
Blister packs of blood thinner Coumadin recalled
Bristol-Myers Squibb is recalling eight lots of its anti-clotting drug Coumadin because the amount of the active ingredient in the drug could change. The company said the recall involves 144,762 units and is precautionary.
Read more
2020-06-17 (consumerreports.org)
Blister packs of blood thinner Coumadin recalled
Bristol-Myers Squibb is recalling eight lots of its anti-clotting drug Coumadin because the amount of the active ingredient in the drug could change. The company said the recall involves 144,762 units and is precautionary.
Read more
2018-08-22 (fiercepharma.com)
Take note, I-O players. Bristol-Myers to sell Opdivo in China at half-price: report
After Bristol-Myers Squibb won the first immuno-oncology nod in China for its PD-1 star Opdivo in June, all parties were holding their breath for its price tag. | The benchmark for prices of future immuno-oncology therapies in China is here.
Read more
2016-10-26 (massdevice.com)
Wound care giant Convatec prices $1.8B IPO
Danish wound care and colostomy supply maker ConvaTec today priced an initial public offering that grossed nearly $1.8 billion on the London Stock Exchange. ConvaTec, which is owned by private equity firms Avista Capital Partners and Nordic Capital, said it put up 33.8% of its shares in the
Read more
2016-10-26 (massdevice.com)
Wound care giant Convatec prices $1.8B IPO
Danish wound care and colostomy supply maker ConvaTec today priced an initial public offering that grossed nearly $1.8 billion on the London Stock Exchange. ConvaTec, which is owned by private equity firms Avista Capital Partners and Nordic Capital, said it put up 33.8% of its shares in the
Read more